HERMES: Effects of ziltivekimab versus placebo on morbidity and mortality in patients with heart failure with mildly reduced or preserved ejection fraction and systemic inflammation (HERMES)

Principal Investigator

James Gamble

Contact us

Email: oxfordheartresearch@ouh.nhs.uk

IRAS number

1006925